Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

SIMPLE SUMMARY: Prostate cancer is a very common disease in men. Nowadays several life-prolonging therapies are available, also efficient in the metastatic setting. However, it is important to choose the best approach for each patient, and in this context molecular biomarkers are fundamental. Baseli...

Descripción completa

Detalles Bibliográficos
Autores principales: Conteduca, Vincenza, Casadei, Chiara, Scarpi, Emanuela, Brighi, Nicole, Schepisi, Giuseppe, Lolli, Cristian, Gurioli, Giorgia, Toma, Ilaria, Poti, Giulia, Farolfi, Alberto, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102454/
https://www.ncbi.nlm.nih.gov/pubmed/35565349
http://dx.doi.org/10.3390/cancers14092219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102454/
https://www.ncbi.nlm.nih.gov/pubmed/35565349
http://dx.doi.org/10.3390/cancers14092219

Ejemplares similares